Home » gilead sciences

You Searched For "gilead sciences"

Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan. (Photo- Twitter)

Gilead ties up with 5 generic drugmakers in India, Pakistan for...

The licenses are royalty-free until the World Health Organization declares the end of the public health emergency...

13 May 2020 8:44 AM IST

Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir. (ANI Photo)

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe...

23 Jun 2020 3:47 PM IST

Medic collects samples of people for COVID-19 testing in Delhi. PTI photo

Health ministry okays remdesivir for moderate cases, HCQ for early...

It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and...

13 Jun 2020 11:35 PM IST

AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc about a potential merger. (AFP Photo)

AstraZeneca approaches Gilead about potential merger

Gilead, AstraZeneca and several other drugmakers are racing to develop vaccines for COVID-19

7 Jun 2020 4:06 PM IST

Indias drug regulator grants Gilead Sciences marketing authorisation for remdesivir. (AFP Photo)

India's drug regulator grants Gilead Sciences marketing authorisation...

The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light...

3 Jun 2020 11:57 AM IST

Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled. (AFP Photo)

Gilead starts testing inhaled version of remdesivir for COVID-19

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with...

9 July 2020 9:10 AM IST

Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial. (AFP Photo)

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

7 July 2020 1:48 PM IST

Vials of the drug remdesivir during a press conference concerning the start of a study with the Ebola drug to treat severely ill patients afflicted with coronavirus COVID-19, at The University Hospital Eppendorf (UKE) in Hamburg, northern Germany, amidst the global pandemic. (AFP)

Remdesivir gets conditional EU clearance to be used in severe COVID-19...

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the...

5 July 2020 1:54 PM IST

Zydus Cadila launched the cheapest generic version of Gilead Sciences antiviral drug remdesivir in India. (Photo- Twitter)

India's cheapest remdesivir version launched by Zydus Cadila at Rs...

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM IST

Dr Reddys launches Remdesivir for COVID-19 treatment in India. (AP Photo)

Dr. Reddy's releases COVID drug Remdesivir under brand name Redyx

"Dr Reddy's Redyx is available in strength of 100 mg vial," it said

9 Sept 2020 12:21 PM IST

US says remdesivir shows clear-cut effect in treating coronavirus. (Photo- Stig Alen¤s | Dreamstime.com)

Remdesivir shows 'clear-cut' effect in treating coronavirus, says US

The finding represents the first time any medication has been shown to improve outcomes against the COVID-19 illness

30 April 2020 9:36 AM IST